01
Healthy Longevity
Functional health, prevention, resilience, healthspan measures and responsible interpretation of longevity outcomes.
Research & Data
Research collaboration, integrity and responsible data use.
IAARM supports multidisciplinary inquiry, comparable methods, responsible data governance and scientific translation proportionate to the evidence.
Research Priorities
Questions with scientific and public-interest relevance.
02
Aging Biology
Mechanisms, biomarkers, measurement validity and the relationship between laboratory findings and human outcomes.
03
Regenerative Medicine
Evidence quality, product characterization, manufacturing, translational safeguards and long-term outcome assessment.
04
Quality & Safety
Process reliability, adverse signals, consent, traceability, risk controls and public communication.
05
Implementation
Professional capability, health-system readiness, equitable access, appropriate adoption and unintended consequences.
06
Claims & Communication
How scientific uncertainty, commercial language and public understanding affect decision quality.
Data Governance
Clinical and research data require dedicated safeguards.
IAARM’s public website does not request or process patient-identifiable clinical information. Activities involving protected or identifiable health data require appropriate ethics review, consent where required, contractual controls, security safeguards and documented data stewardship.
Research contributors remain responsible for all local legal, regulatory, ethical and institutional approvals.
Research Integrity
Funding and collaboration must be visible.
01
Protocol Transparency
Questions, methods, outcomes, exclusions and analysis plans should be documented before interpretation.
02
Contribution & Interests
Authorship, contributor roles, funding, data access and competing interests must be disclosed.
03
Correction & Reproducibility
Material errors, reanalysis, limitations and changes to conclusions require visible correction pathways.